Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ALXO compared with ARTV: revenue, margins and what each company keeps, and the suppliers and customers both name
ALXO
ALX Oncology Holdings Inc
Change
Mkt cap
Revenue
Revenue
ARTV
Artiva Biotherapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
ALXO
ALX Oncology Holdings Inc
vs
ARTV
Artiva Biotherapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
ALXO
ALX Oncology Holdings Inc
Change
1.24
▲
+1.38%
· post 1.24
Mkt cap
$168.7M
Revenue
—
ARTV
Artiva Biotherapeutics, Inc.
Change
4.19
▼
−0.98%
· post 4.19
Closed
Oct 30 '26
Mkt cap
$204.8M
Revenue
$251,000
Q1 FY24
vs
Compare
Closed
Oct 30 '26
ALXO
ALX Oncology Holdings Inc
vs
ARTV
Artiva Biotherapeutics, Inc.
1.24
▲
+1.38%
post 1.24
Price
4.19
▼
−0.98%
post 4.19
$168.7M
Mkt cap
$204.8M
—
Revenue
$251,000
Q1 FY24
Change
Change
ALXO
1.24
▲
+1.38%
vs
ARTV
4.19
▼
−0.98%
Closed
Oct 30 '26
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
ALXO, solid
ARTV, dashed
Supply-chain overlap
Revenue flow
ALXO: latest quarter not drawable. ARTV: latest quarter is a loss; flow not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only ALXO
15
LLY
Eli Lilly
supplier
USB
U.S. Bank
supplier
JAZZ
Jazz Pharmaceuticals plc (Jazz)
supplier
SNY
Sanofi
supplier
11 more · ALXO chain
›
Shared
0
No shared counterparties.
Only ARTV
1
—
GC Cell
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR